Yifeng Pharmacy (603939) - Total Liabilities

Latest as of September 2025: CN¥14.41 Billion CNY ≈ $2.11 Billion USD

Based on the latest financial reports, Yifeng Pharmacy (603939) has total liabilities worth CN¥14.41 Billion CNY (≈ $2.11 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore investment intensity of Yifeng Pharmacy to see how much of total assets are deployed in long-term investments.

Yifeng Pharmacy - Total Liabilities Trend (2011–2024)

This chart illustrates how Yifeng Pharmacy's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Yifeng Pharmacy assets under control.

Yifeng Pharmacy Competitors by Total Liabilities

The table below lists competitors of Yifeng Pharmacy ranked by their total liabilities.

Company	Country	Total Liabilities
Allete Inc NYSE:ALE	USA	$3.81 Billion
Veradermics, Incorporated NYSE:MANE	USA	$6.72 Million
Pangang Group Vanadium Titanium & Resources Co Ltd SHE:000629	China	CN¥1.99 Billion
Oscar Health Inc NYSE:OSCR	USA	$5.34 Billion
Liaoning Port Co Ltd SHG:601880	China	CN¥13.29 Billion
Aris Mining Corporation NYSE MKT:ARMN	USA	$977.30 Million
Boot Barn Holdings Inc NYSE:BOOT	USA	$1.12 Billion
AGL Energy Ltd AU:AGL	Australia	AU$11.04 Billion

Liability Composition Analysis (2011–2024)

This chart breaks down Yifeng Pharmacy's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Yifeng Pharmacy's balance sheet to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.42	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.32	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.55	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Yifeng Pharmacy's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Yifeng Pharmacy (2011–2024)

The table below shows the annual total liabilities of Yifeng Pharmacy from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥16.58 Billion ≈ $2.43 Billion	+21.12%
2023-12-31	CN¥13.69 Billion ≈ $2.00 Billion	+14.87%
2022-12-31	CN¥11.92 Billion ≈ $1.74 Billion	+29.71%
2021-12-31	CN¥9.19 Billion ≈ $1.34 Billion	+28.18%
2020-12-31	CN¥7.17 Billion ≈ $1.05 Billion	+60.49%
2019-12-31	CN¥4.47 Billion ≈ $653.56 Million	+20.77%
2018-12-31	CN¥3.70 Billion ≈ $541.18 Million	+130.72%
2017-12-31	CN¥1.60 Billion ≈ $234.56 Million	+28.65%
2016-12-31	CN¥1.25 Billion ≈ $182.31 Million	+22.47%
2015-12-31	CN¥1.02 Billion ≈ $148.86 Million	+55.27%
2014-12-31	CN¥655.19 Million ≈ $95.87 Million	+24.99%
2013-12-31	CN¥524.21 Million ≈ $76.71 Million	+24.92%
2012-12-31	CN¥419.63 Million ≈ $61.40 Million	-13.86%
2011-12-31	CN¥487.12 Million ≈ $71.28 Million	--

About Yifeng Pharmacy

SHG:603939 China Pharmaceutical Retailers

Market Cap

$3.94 Billion

CN¥26.92 Billion CNY

Market Cap Rank

#4184 Global

#643 in China

Share Price

CN¥22.20

Change (1 day)

+0.23%

52-Week Range

CN¥17.98 - CN¥25.49

All Time High

CN¥967.78